InvestorsHub Logo

medical veteran

02/11/21 8:19 AM

#13730 RE: yman #13729

YYMAN- I think the challenges that NNLX faces is that its past has been sketchy at best. Unless you have angel investors, PE/VC funding the cash required is huge to bring this thing to flourish'n. Selling non restrictive shares is not even close to the monies you need to pull this off. The so called results that NNLX states there test can produce is nothing more then words. The patents do not prove those results. It sounds good but it means nothing until its in a working model and the results can be truly measured/confirmed and the FDA says, this is a game changer.

Finding a partner is another serious challenge. A partner has to have enormous confidence in NNLX to spend tens of millions of dollars required to tool up production, marketing, packaging, paperwork filings to the FDA and everything in-between. Then, after the tens of millions are spent can that partner make any money after the pie is cut to make it a worthwhile endeavor. Then, throw in how far behind the Magic 8 ball they are to all the other companies who have already brought product to market and are on the second round fine tuning there current technology.

These other companies also have a major leg up with the FDA and an experienced top notch team in place who are pro's in bringing product and technology to market. If your playing the penny game from 4 cents to 11 cent, and playing the penny percentage game, that is where any penny money is to be made. Everything else, in my opinion only, is a pipe dream based on what I see at the moment and its past history. It's not bashing, its just stating the facts and the current reality based on my own personal opinion. Everyone should come to there own conclusion!!

Omar8

02/11/21 11:43 AM

#13736 RE: yman #13729

yman,







It's pretty much 4 months ago this below, why hasn't the Company updated the shareholders on if it was successful or not ? Could it be they still working on it ? If it's taking that long to get it going then maybe the tech is needing a lot more developing to make it a working product ? An update to shareholders would clear things up but that's not important to them it seems since they haven't followed up on this ? Apparently at the time of this release it was important to release this news but a follow up wasn't what they feel is needed now nearly 4 months later ?




"Oct. 14, 2020

NanoLogix Is Researching FDA EUA Requirements For COVID-19 Testing Related to Recently Allowed Patent

1st For Whole Virus Detection, 2nd For Antibody Detection

NanoLogix Welcomes David R. Barnhizer as Vice President For Strategic Analysis and Development

NanoLogix is researching FDA requirements for EUA's for two of the 25 covered claims in the recently allowed patent application focused upon Rapid Virus Detection. Now that there has been allowance for issue of the patent with all 25 claims allowed, NanoLogix can justify devoting resources to this process and specifics.

Upon successful results for work currently being performed by a third party to apply NanoLogix technology to a separate testing platform for COVID19 detection, other applications may follow. Once the patent is issued we will reveal the broad and detailed extent of allowed claims for this technology.